Concepedia

Maria Teresa Ionta

MT

21

Publications

619

Citations

15

H-Index

1995

Active since

Affiliations

University of Cagliari(Current)

Istituti di Ricovero e Cura a Carattere Scientifico

Mario Negri Institute for Pharmacological Research

Fondazione IRCCS Istituto Nazionale dei Tumori

Ospedale Papa Giovanni XXIII

Maria Teresa Ionta is an author at University of Cagliari specializing in medicine, cancer therapeutics, and oncology.

Top concepts

Publications per year

1995–2021

21

Publications

21

Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer

Emilio Bajetta, Irene Floriani, Maria Di Bartolomeo et al. · Annals of Oncology · 2014 · 89 citations · Full text

, , +10

Dihydropyrimidine dehydrogenase pharmacogenetics for predicting fluoropyrimidine-related toxicity in the randomised, phase III adjuvant TOSCA trial in high-risk colon cancer patients

Annamaria Ruzzo, Francesco Graziano, Fabio Galli et al. · British Journal of Cancer · 2017 · 68 citations · Full text

Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: a population-based study

Grazia Palomba, Valentina Doneddu, Antonio Cossu et al. · Journal of Translational Medicine · 2016 · 55 citations · Full text

Phase III trial comparing 3–6 months of adjuvant FOLFOX4/XELOX in stage II–III colon cancer: safety and compliance in the TOSCA trial

Sara Lonardi, Alberto Sobrero, Gerardo Rosati et al. · Annals of Oncology · 2016 · 54 citations · Full text

, , +9

Thyroid Dysfunction in Patients with Metastatic Carcinoma Treated with Sunitinib: Is Thyroid Autoimmunity Involved?

Fabiana Pani, Francesco Atzori, Germana Baghino et al. · Thyroid · 2015 · 45 citations · Full text

Rows per page

1–5 of 21